Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 6, 2008 Brian Orelli	Illumina Grabs Some Cash With biochip maker Illumina hitting 52-week highs, it seems inevitable that the company would do a secondary offering to grab some cash -- about $300 million, as it turns out.
InternetNews January 30, 2007 Roy Mark	Second Look For Dynamic Web Patents The U.S. Patent and Trademark Office will review two patents held by EpicRealm, a Texas firm that has filed a number of infringement lawsuits against companies employing dynamic Web technology.
InternetNews July 31, 2007 Larry Barrett	RealNetworks Case Highlights Sea-Change In Patent Law Supreme Court ruling puts patent trolls on notice.
The Motley Fool August 12, 2009 Brian Orelli	The Next Big Thing Is Not Right in Front of You Perhaps the fastest evolving technology right now is found in DNA sequencing.
The Motley Fool April 27, 2011 Brian Orelli	Illuminating the Growth Competition in the DNA sequencing market may be heating up, but 47% growth for Illumina isn't too shabby.
Entrepreneur September 2006 Jane Easter Bahls	Toppling Trolls Patent trolls take a hit in a Supreme Court ruling.
The Motley Fool August 18, 2010 Luke Timmerman	Life Technologies Competes for Cheap DNA Sequencing In the race to cheaper gene sequencing.
The Motley Fool February 13, 2008 Stephen Albainy-Jenei	One Privileged Position Biomedical Patent Management sued the California Department of Health Services, claiming patent infringement, but the State of California can claim immunity from patent suits.
Chemistry World January 30, 2015 Rebecca Trager	Myriad calls a ceasefire in court battle over cancer gene tests Myriad Genetics has ended its bid to prevent other companies from producing tests for genetic mutations associated with an increased risk of breast and ovarian cancer that it owned patents on.
The Motley Fool July 24, 2008 Brian Orelli	Illumina Polishes Its Biochips There's very little to complain about in Illumina's earnings report. In this market, you'll see few investors grumbling about double-digit growth.
The Motley Fool July 1, 2011 Dan Radovsky	Can the Human Genetics Industry Survive the Courts? The future of gene patents is at stake.
InternetNews June 9, 2011	Microsoft Loses Supreme Court Patent Case Top U.S. court rules against Microsoft in i4i patent appeal.
The Motley Fool August 31, 2011 John Grgurich	How the Patent Wars Are Hurting High-Tech Well-intentioned patent laws are threatening to stifle innovation.
InternetNews August 31, 2010	Microsoft Appeals Patent Case to Supreme Court Microsoft plays out its hand in effort to reverse the USPTO's ruling that upheld the patent of Toronto-based i4i relating to a custom XML technology.
Bank Systems & Technology June 29, 2010 Matt Gunn	Supreme Court Rejects Business Method Patent Ruling in Bilski v. Kappos doesn't shut door on business method patents, but doesn't clarify them either.
The Motley Fool March 30, 2007 Ralph Casale	Another Genetic Sequencer Gobbled Up Roche buys out second-generation sequencer 454 Life Sciences. Investors, take note.
The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.
BusinessWeek March 25, 2010 Susan Decker	Attention, Shoppers: This Patent Expired Products marked with out-of-date claims are provoking a wave of lawsuits from consumers
InternetNews November 30, 2010	Microsoft's i4i Appeal Headed for Supreme Court Microsoft will get a chance to make its case to the U.S. Supreme Court, appealing the earlier patent infringement decision it lost to i4i.
Information Today September 6, 2012 Paula J. Hane	Apple-Samsung Case Highlights America's Troubled Patent System The jury finding in this case has triggered an onslaught of commentary and has also brought up many questions about the nature of the U.S. patent system. The comments have ranged from "software patents are evil" to the U.S. has a "broken patent system."
Chemistry World January 7, 2015 Rebecca Trager	Myriad loses appeal on cancer gene test patents Myriad Genetics has lost its appeal over patents on the BRCA genes that are associated with a higher risk of breast and ovarian cancer.
Bio-IT World November 12, 2002 Andrew W. Torrance	After the Gene Rush About 20,000 gene-related patents have been granted in the U.S. so far, with twice as many on the way. The practical and political challenges are equally large.
Bank Systems & Technology May 24, 2007 Maria Bruno-Britz	Banks Need Patents, Experts Say In light of recent patent litigation, banks must understand the importance of protecting their innovations.
The Motley Fool October 3, 2007 Rich Duprey	No Patents on Thinking ... Yet Over the years, the U.S. Patent office has patented a few too many ideas. The Supreme Court is now spending more time deciding whether a company has really infringed on a patent, rather than automatically issuing an infringement.
Bio-IT World June 17, 2004 Cathryn Campbell	Patent Plaintiff Perils Suing for patent infringement may seem rewarding, but you could lose even more.
PC Magazine July 4, 2008 Adam K. Cramer	Giving Patents an Upgrade Lawsuits are hurting big tech companies, some of which are calling for an overhaul to the patent system.
The Motley Fool May 17, 2006 Rich Duprey	A Patently Offensive Ruling? eBay vs. MercExchange was the wrong ruling in the right case. Rather than balancing the power between "patent trolls" and innovation, this ruling could end up tipping the scales against small-time inventors who lack the resources to challenge corporations that usurp a patent's advancements.
Entrepreneur October 2005 Chris Penttila	Patent Pending Have an idea for the next big thing? You'll need a patent, but pay attention to big changes in store for U.S. patent law.
Chemistry World April 19, 2013 Sarah Houlton	Thermo Fisher to buy Life Technologies in $15.8bn deal Life Technologies specializes in research products, with a particular focus on genetic sequencing and DNA analysis.
Bio-IT World November 12, 2002 Beth E. Arnold	Navigating Gene Patent Minefields As the number of gene-related patents soars, so do the chances of patent infringement. Here are tips to avoid a costly misstep in this legal minefield.
BusinessWeek May 14, 2007 Michael Orey	A Higher Hurdle For Inventors Has it become too easy to win and defend patents? The Supreme Court says yes.
The Motley Fool February 6, 2008 Brian Orelli	Insatiable Illumina Revenue is way up at Illumina, but can the company keep it going looking forward?
Information Today July 6, 2010 George H. Pike	Supreme Court Confirms Patentability of Business Methods, Denies Bilski Patent The lengthy and complex decision, entitled Bilski v. Kappos, affirmed the legality of business method patents, while leaving unanswered some questions about the scope and breadth of such patents.
Information Today July 2, 2013 George H. Pike	Why Patent Litigation Was on the Upswing in 2012 2012 was a "banner year in patent litigation," with increases in the number of patent infringement lawsuits filed in the federal courts and larger damage awards.
Chemistry World August 22, 2014 Phillip Broadwith	Illumina targets cancer diagnostics Genetic sequencing heavyweight Illumina has partnered with three major pharmaceutical firms in a bid to develop a universal sequencing-based oncology test system.
InternetNews May 10, 2007 Roy Mark	Vonage Playing Supreme Court Card Vonage claims a recent Supreme Court ruling will make it obvious company didn't infringe on Verizon patents.
InternetNews March 3, 2006 Roy Mark	Trolling for Patents Patent infringement claims are easy to make and difficult to disprove.
IndustryWeek December 1, 2007 Jill Jusko	Trying Times for IP Protection Intellectual property disputes appear on the upswing as other litigation declines.
The Motley Fool January 11, 2008 Brian Orelli	Biochip Packaging: Some Settling May Occur Biochip maker Illumina settles its disputes about patents with Affymetrix.
BusinessWeek January 9, 2006 Michael Orey	The Patent Epidemic Overpatenting is wasting companies' money and slowing the development of new products.
InternetNews April 18, 2007 Roy Mark	Dems, Republicans Unite on Patent Reform Identical bills introduced in House and Senate to reduce infringement awards and to change Patent Office procedures.
PC Magazine April 6, 2005 John C. Dvorak	Software Patents: Microsoft's Fatal Error Microsoft's has a lot to worry about as the European Union looks unfavorably on its hidden source code and patent practices.
The Motley Fool January 14, 2010 Brian Orelli	$1,000 Genomes, Here We Come Illumina jumps on news of its $10,000 genome.
InternetNews July 14, 2004 Susan Kuchinskas	Streaming Media Dispute Closer to Trial A preliminary Markman Order sets out the terms of the patent infringement dispute between Acacia and 11 porn sites.
InternetNews July 28, 2010	USPTO Deals Microsoft Setback in i4i Patent Case U.S. Patent and Trademark Office upholds Canadian firm i4i's patent for a custom XML editor, further narrowing Microsoft's options in a $290 million infringement case.
Pharmaceutical Executive May 1, 2005 Margaret Buck	Legal: No Exception? An important legal loophole has made patented tools available for biotech research. Today, though, it appears to be closing.
The Motley Fool September 17, 2011	What's Fueling the Tech Patent Bull Market? As companies amass patents to sue each other, is it time for the patent system to be reformed?
Inc. June 2006 Athena Schindelheim	Great Moments In Patent History With the blockbuster BlackBerry settlement and a case involving eBay before the Supreme Court, the dowdy world of patent law is suddenly hot.
The Motley Fool March 13, 2008 Stephen Albainy-Jenei	Pfizer's Celebrex Aches and Pains The Court of Appeals for the Federal Circuit upholds a lower court's ruling that found Teva Pharmaceutical had infringed two of Pfizer's patents for Celebrex.
InternetNews November 28, 2006 Roy Mark	High Court Debates Patent Challenges A highly engaged United States Supreme Court heard oral arguments today in a case that could have wide implications for the future of the country's patent system.